G1 Therapeutics (NASDAQ:GTHX) stock is rocketing higher on Wednesday after the company announced an acquisition deal with Pharmacosmos Group. Pharmacosmos Group has agreed to acquire all outstanding shares of GTHX stock for $7.15 in cash. That represents a 68% premium to G1 Therapeutics' prior closing price. It's also a 133% premium to its 30-day volume weighted average price. This deal will have Pharmacosmos Group paying a total of $405 million for G1 Therapeutics. It's using current cash on hand and its e ...